[Ventriculitis due to Haemophilus aphrophilus in a 21 year old patient and right-left shunt].
Villanueva Anadón
B
B
Claramonte Delaviuda
M
M
Zalba Etayo
B
B
Obón Azuara
B
B
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001922:Brain Abscess / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D002543:Cerebral Hemorrhage / Q000209:etiology; D058565:Cerebral Ventriculitis / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D004198:Disease Susceptibility; D054092:Foramen Ovale, Patent / Q000150:complications*; D006192:Haemophilus Infections / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D044136:Haemophilus paraphrophilus / Q000302:isolation & purification* / Q000502:physiology; D006352:Heart Ventricles / Q000382:microbiology; D006801:Humans; D006849:Hydrocephalus / Q000209:etiology; D006935:Hypercapnia / Q000209:etiology / Q000382:microbiology; D008297:Male; D011183:Postoperative Complications / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D012121:Respiration, Artificial; D013771:Tetralogy of Fallot / Q000150:complications* / Q000601:surgery; D018497:Ventricular Dysfunction, Right / Q000209:etiology*; D055815:Young Adult
D000900:Anti-Bacterial Agents